These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14584357)

  • 1. Prescribing NSAIDs in practice.
    Fernandes C; Bird H
    Practitioner; 2003 Oct; 247(1651):796-9. PubMed ID: 14584357
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
    Lipsky PE; Abramson SB; Breedveld FC; Brook P; Burmester R; Buttgereit F; Cannon GW; Catella-Lawson F; Crofford LJ; Doherty M; Dougados M; DuBois RN; Froelich J; Garcia Rodriguez LA; Gibofsky A; Hernandez-Diaz S; Hochberg MC; Krause A; Liang MH; Machold K; Peloso PM; Raisz LG; Schayes B; Scheiman JM; Simon LS; Smolen J
    J Rheumatol; 2000 Jun; 27(6):1338-40. PubMed ID: 10852251
    [No Abstract]   [Full Text] [Related]  

  • 3. [Safe use of anti-inflammatory analgesics].
    Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
    Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cyclo-oxygenase 2 inhibitors and cancer].
    André T; Soria JC
    Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C
    Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland.
    Girvin B; Rafferty T; Stevenson MR; Johnston GD
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):153-7. PubMed ID: 15072114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoarthritis. Responding to the patient's needs.
    Mant A
    Aust Fam Physician; 2000 Jul; 29(7):671-2. PubMed ID: 10914453
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy (Br J Surg 2003; 90: 1055-1067).
    Nash G
    Br J Surg; 2003 Dec; 90(12):1610. PubMed ID: 14648750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intra-spinal mechanism of inflammatory pain--special reference to PGE2].
    Ikoma M; Baba H
    Masui; 2003 Dec; 52 Suppl():S34-46. PubMed ID: 14870563
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cyclooxygenases in the spinal cord and the relationship with pain].
    Li SQ; Li WB
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
    Davis P; Juby A; Robertson S; Richard N
    J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
    [No Abstract]   [Full Text] [Related]  

  • 14. COX2-alternatives and GI protection.
    Med Lett Drugs Ther; 2004 Nov; 46(1195):91-2. PubMed ID: 15534567
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase inhibition in patients with coronary artery disease.
    Frishman WH
    J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-steroidal anti-inflammatories. Principles and utilization rules].
    Bannwarth B
    Rev Prat; 1998 May; 48(9):1011-7. PubMed ID: 11767343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.